|
|
Nventa Biopharmaceuticals Corporation - Price Analysis Snapshot
This Report features up to a ten-year record of the equity Price history for Nventa Biopharmaceuticals Corporation. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
Nventa Biopharmaceuticals Corporation. The Group's principal activity is to discover, develop and commercialize innovative stress protein-based immunotherapeutics, also known as therapeutic vaccines, which are used for the treatment of infectious diseases and cancers. The Group uses a specific and unique class of proteins, called stress proteins, to regulate immune responses for therapeutic applications. The Group has market for its products in the United States, Canada and other Countries.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|